ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 105 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,265 | -11.8% | 6,900 | +33.5% | 0.00% | 0.0% |
| Q2 2023 | $53,603 | +28.2% | 5,169 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $41,817 | -51.2% | 5,169 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $85,754 | +20.8% | 5,169 | +13.9% | 0.00% | 0.0% |
| Q3 2022 | $71,000 | +12.7% | 4,539 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $63,000 | -8.7% | 4,539 | +14.1% | 0.00% | +50.0% |
| Q1 2022 | $69,000 | +19.0% | 3,979 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $58,000 | -19.4% | 3,979 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $72,000 | +20.0% | 3,979 | +16.9% | 0.00% | +50.0% |
| Q2 2021 | $60,000 | +2900.0% | 3,404 | +52.1% | 0.00% | – |
| Q1 2020 | $2,000 | -50.0% | 2,238 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 2,238 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -60.0% | 2,238 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -61.5% | 2,238 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $13,000 | -23.5% | 2,238 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $17,000 | -46.9% | 2,238 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $32,000 | -28.9% | 2,238 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $45,000 | +45.2% | 2,238 | +26.5% | 0.00% | +100.0% |
| Q1 2018 | $31,000 | -29.5% | 1,769 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $44,000 | -2.2% | 1,769 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $45,000 | -6.2% | 1,769 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $48,000 | +128.6% | 1,769 | +152.0% | 0.00% | +100.0% |
| Q1 2017 | $21,000 | – | 702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |